Oscar Health, Inc. (NYSE:OSCR) Given Consensus Recommendation of “Hold” by Brokerages

Oscar Health, Inc. (NYSE:OSCR) has been assigned an average recommendation of “Hold” from the nine brokerages that are currently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, two have issued a hold recommendation, four have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $21.56.

Several equities research analysts recently commented on OSCR shares. Bank of America lowered shares of Oscar Health from a “neutral” rating to an “underperform” rating and decreased their price objective for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. Jefferies Financial Group started coverage on shares of Oscar Health in a report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price target on the stock.

Insiders Place Their Bets

In other news, CAO Victoria Baltrus sold 8,078 shares of the firm’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $146,050.24. Following the sale, the chief accounting officer now owns 146,036 shares in the company, valued at $2,640,330.88. This trade represents a 5.24 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $17.05, for a total value of $426,250.00. Following the completion of the sale, the director now directly owns 89,512 shares of the company’s stock, valued at approximately $1,526,179.60. This represents a 21.83 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 103,610 shares of company stock valued at $1,847,519 in the last ninety days. Insiders own 25.11% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. JPMorgan Chase & Co. increased its position in Oscar Health by 348.7% during the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock worth $139,246,000 after purchasing an additional 8,051,379 shares during the last quarter. BIT Capital GmbH grew its stake in shares of Oscar Health by 5,711.6% during the 4th quarter. BIT Capital GmbH now owns 4,473,853 shares of the company’s stock valued at $60,129,000 after buying an additional 4,396,872 shares during the period. Hennessy Advisors Inc. increased its holdings in shares of Oscar Health by 550.3% during the 4th quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock worth $56,292,000 after buying an additional 3,544,300 shares during the last quarter. Clearbridge Investments LLC purchased a new position in shares of Oscar Health in the 4th quarter worth $19,088,000. Finally, Westfield Capital Management Co. LP acquired a new position in Oscar Health in the third quarter valued at $27,452,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Price Performance

Shares of OSCR stock opened at $13.75 on Thursday. The stock has a 50 day simple moving average of $14.87 and a 200-day simple moving average of $16.80. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. Oscar Health has a 12-month low of $13.05 and a 12-month high of $23.79.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. Equities research analysts expect that Oscar Health will post 0.91 earnings per share for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.